Direct antiGBM antibody induced alterations in gloinerular permselectivity. The glomerular fixation of anti-glomerular-basement--membrane (antiGBM) antibody is associated with complement activation, neutrophil accumulation, and renal injury. This injury manifests both as an increase in the rate of urinary protein excretion and altered renal hemodynamic characteristics. We have utilized an isolated perfused kidney system (IPK) to assess the capacity of antiGBM antibody to alter glomerular permselectivity in the absence of both glomerular complement activation and neutrophil infiltration. Control perfusions with Krebs-Henseleit buffered 5% albumin solutions containing normal sheep globulin had a protein excretion rate of 0.223 0.044 mg/mm (mean sEM). Assessment of glomerular perniselectivity using fractional dextran clearances demonstrated an intact negative charge barrier in control preparations. AntiGBM antibody bound in a dose related fashion to the kidney and was localized to the glomerular basement membrane on immunofluorescence. Antibody induced a significant increase in mean protein excretion (2.009 0.681 mg/mm, P < 0.01) in association with a loss of the glomerular filter's negative charge barrier.
mediators (such as complement) and a direct effect of antibody itself. Some experimental studies suggest that antibody may induce injury without clear-cut evidence of PMN or complement involvement. Avian and occasional mammalian antiGBM antibodies produce proteinuria in both rats and rabbits without significant complement fixation or cellular infiltration [8, [15] [16] .
In the guinea pig, injury has been observed despite both complement and neutrophil depletion [17-201. In vivo studies usually investigate the role of any proposed inflammatory mediator by assessing the effects of mediator depletion on a particular model of experimental glomerulonephritis. However, no matter how stringent the controls, depletion experiments are always subject to the criticism that other known or unknown modulators of injury may also be affected by the manipulations used to induce depletion. The conclusions drawn from all depletional studies are inferential.
The specific repletion of a putative mediator allows direct evaluation of its role in acute antiGBM glomerulonephritis. However, the sequential repletion of the proposed inflammatory mediators (that is, antibody, complement, and neutrophils)
is not feasible in vivo. For these reasons, we have used an isolated perfused rat kidney to allow assessment of the effects on renal function of antiGBM antibody in the absence of circulating soluble inflammatory mediators and inflammatory cells. The IPK has recently been shown to be a suitable system with which to study glomerular permselectivity [21] . A preliminary communication by Couser et al [221 had suggested that antibody administration produced an increase in protein excretion in such a system. Recent studies have demonstrated the importance of an intact GBM negative charge barrier in the maintenance of normal glomerular perselectivity characteristics, and the loss of this charge barrier in a variety of pathologic states . We sought to quantitatively assess the effects of antiGBM antibody binding on the protein excretion rate of the IPK and to assess the functional effects of antiGBM antibody on glomerular perrnselectivity in this circulating-cell free systern.
Methods

Perfusion technique
The perfusion apparatus used in these experiments was similar to that described by Bowman and Maack [281 and modified by Nakane et al [29] and Epstein et al [301. The apparatus consisted of a central glass reservoir containing the perfusate which was recirculated by a roller peristaltic pump (Watson-Marlow, London, UK). The perfusate traversed two bubble traps and two 8 t filters (Millipore, Bedford, Massachusetts, USA) before being gassed with a mixture of 95% 02/5% CO2 and delivered to the glass arterial perfusion cannula (P.A. Brooks, Ducklington, UK).
Male Sprague-Dawley (SD) rats (300 to 450 g) were anesthetized with an intraperitoneal injection of pentobarbital (40 mg/kg). A laparotomy was performed after injection of 1 ml of 10% mannitol and 500 IU sodium heparin (Commonwealth Serum Laboratories, Melbourne, Australia) into the left femoral vein. The right ureter was cannulated with polyethylene tubing (PE1O, Intramedic, Parsippany, New Jersey, USA). The right renal artery was cannulated via the superior mesenteric artery and the kidney perfused during en-bloc dissection. After removal, the kidney surface was rinsed with phosphate buffered saline (PBS) and 20 to 40 ml of perfusate flushed through the renal vasculature before transferring the kidney to a support above the central reservoir. The renal vein was not cannulated.
The kidney was allowed to equilibrate for 10 minutes In all experiments the perfusate flow rate was >20 mllmin at a cannula tip pressure <120 mm Hg by the end of this equilibration period. The kidney was covered with a paraffin film (Nescofilm, Bando Chemical md. Ltd., Kobe, Japan) and perfused for periods up to 150 minutes. Samples of perfusate were taken at 10 minute intervals and urine was collected over 20 minute intervals. All samples were stored at -20°C prior to assay. Globulin fractions were added to the perfusate reservoir at the end of the equilibration period (that is, t0). The IPK perfusate consisted of a buffered albumin solution (BAS); Krebs-Henseleit buffer containing 5.0 g/liter bovine serum albumin (Sigma Chemical, St. Louis, Missouri, USA) with added creatinine (10 to 20 mg/liter), glucose (5 mM/liter) and amino acids [30] . It was prefiltered and then passed through a 0.22 filter (Millipore, Bedford, Massachusetts, USA) before use within eight hours of preparation. The perfusate total hemolytic complement activity (CH50) was assessed using previously described techniques [31] , and at all times there was no demonstrable complement activity (CH50 = 0 units). Cell counts performed on perfusate sampled from the perfusate reservoir were at all times 0.0 cells/ml.
Assessment of renal function Protein excretion. This was measured in duplicate samples by the Coomassie Brilliant Blue dye binding assay [32] .
Glomerular filtration rate (GFR). This was measured in duplicate samples by either 3H-inulin clearance or creatinine clearance techniques. These techniques give equivalent GFR estimates in the IPK [33] . Control (N=6) and antiGBM antibody treated (N=6) IPK's in this laboratory had equivalent Renal vascular resistance (RVR). Perfusate pressure was measured proximal to the arterial cannula with a calibrated aneroid manometer. The cannula tip pressures were derived by subtracting from the measured pressure the pressure drop known to occur across a particular arterial cannula (of known resistance at a given flow). Perfusate flow was measured by a drop counter above the central reservoir Then, resistance = cannula tip pressure (mm Hg)/perfusate flow (ml/min) Creatinine (Cr) estimates. Creatinine was determined using a colorimetric automated analyzer (Beckman Instruments, Pal Alto, California, USA). Creatinine clearance was used in the calculation of filtration fraction. This was equal to previously described values (0.2 0.01) in all IPK preparations in the current study. Glomerular permselectivity studies: (A) Preparation of radiolabelled dextrans. Radiolabelled neutral dextrans of a wide molecular size distribution were prepared by oxidation of commercial dextrans of known size (Tb, T40, T70, Pharmacia Fine Chemicals, Uppsala, Sweden) by periodate and subsequent reduction by tritiated sodium borohydride (Amersham, Sydney, Australia) according to the method of Chang et al [24] .
Perfusate dextran concentrations were maintained at 100 mg/liter or less.
Radiolabelled dextran sulphate of a wide molecular size distribution was prepared by hydrolyzing commercially available dextran sulphate (Pharmacia Fine Chemicals, mol wt 500,000) to an appropriate lower molecular weight fraction using a modification [21] of the technique described by Chang et al [25] , where the duration of acid hydrolysis at 100°C was reduced to 20 minutes. The tritium label was then introduced by the same oxidation-reduction formula utilized for neutral dextrans.
(B) Chromatographic procedures. Sephadex G100 (Pharmacia) was used with a 0.05 N solution of ammonium acetate as buffer. Chromatographic columns [(1.6 cm ID x 100 cm) and (1.8 ID x 120 cm)] (Pharmacia) were used. Eluted fractions were collected with an automatic fractionator (LKB Wallac, ULTRARAC 7000, Stockholm, Sweden). The columns were calibrated using bovine serum albumin (Sigma, trypsinogen, carbonic anhydrase, and lysozyme. Blue dextran (2 mg/ml) was used to determine the void volume (Vo). The fractional volume available to the solute (KAy) was calculated, and this related to the molecular weight and Stokes Einstein radii of eluted fractions using the methods described by Chang et al (27) . The specific activities of the tritiated dextrans were determined using a liquid scintillation spectrometer (LKB Wallac, ULTRABETA) with scintillation produced by mixing 1 ml of aqueous sample with 5 ml of scintillation fluid.
(C) The origin of urinary protein in the IPK was further Sheep-antirat GBM globulin (antiGBM antibody). Sheep were repeatedly immunized with particulate SD GBM as previously described [34] . When a high titer of antiGBM antibody was established, as determined by radioimmunoassay (RIA) the sheep was sacrificed. The sera was absorbed and a globulin fraction prepared as for NSG.
Quantitation of antibody binding. Globulin binding studies were performed as previously described [35] by trace radiolabelling the globulin (NSG or antiGBM-Ab with '31lodine and '2tlodine, respectively) using the Chloramine-T technique [36] .
Trace labelled globulin was added at the end of the IPK equilibration period to a known volume of perfusate, and perfusate was sampled after thorough mixing had occurred for determination of its specific activity. At the desired time the kidney was removed from the perfusion apparatus, trimmed of capsule, excess connective tissue and fat and the renal cortex dissected free. The cortex was then weighed before being homogenized in a glass tube homogenizer. The homogenate was repeatedly washed in 50 ml of PBS then spun at 500 x g for five minutes. This was repeated until the supernatant was clear. From the quantities of radioactivity in the final pellet (LKB Wallac, 1280 Ultragamma) and the specific activities of the perfusate, the quantity of globulin bound to the kidney was determined and expressed as sg of globulin bound to each gram of renal cortex (.tg/g). Specific antibody binding [kidney fixed antibody (KFA)] was calculated as previously reported [35] .
Experimental design
In all experiments the IPK was allowed to equilibrate for 10 minutes prior to the addition of antibodies, at to. the maximal antibody concentrations achieved (1 mg/mI). The antibody binding (KFA) was assessed by studying the quantity of specifically bound antibody at 120 minutes.
Statistical methods
Data is expressed as mean SCM. Significance was determined using the Student's t-test for the comparison of means and by the analysis of variance [37] . Results (Table 1 , Fig. 1 ) Isolated rat kidneys, perfused with a buffered albumin solution with added normal sheep globulin (1 mg/ml) had stable function for the 120 minutes of the study. Over this period the protein excretion was (mean sCM) 0.223 0.044 mg/mm, GFR (mean sCM) 0.63 0.08 ml/min/g and RVR (mean sCM) 3.10 0.47mm Hg/mi/mm. IF was negative for sheep IgG and rat C3. There was no proximal tubule epithelial staining for rat globulin in control preparations perfused with rat antiFXlA antibody.
BAS Perfused controls
Neutral dextran (N - 8) and Dextran sulphate (N = 6) perfusions of BAS controls showed glomerular permselectivity 668 Boyce and Holdsworth AntiGBM-Ab binding (KFA 385 g/g) produced a marked increase in protein excretion rate (overall mean SEM; 2.009 0.681 mg/mm, P < 0.01). Antibody administration also produced hemodynamic changes [at KFA 385 g/g, an increased RYR (4.83 0.52 mm Hg/ml/min, P < 0.01), a decreased GFR (0.34 0.04 mllminlg, P < 0.01), at KFA 183 g/g, an increased RVR (4.72 0.48 mm Hg/mi min1, P < 0.01) and a decreased GFR (0.41 0.05 mllmin/g, P < 0.01)]. There were equivalent hemodynamic alterations at both these antibody binding levels, characteristics substantially similar to those reported for the SD and Munich-Wistar rats in vivo, as we have reported elsewhere [21] . In particular, the negative charge barrier on the glomerular filter was intact (such as, fractional clearance of neutral dextran 36A radius = 0.10 0.01, cf. fractional clearance of negatively charged dextran sulphate 0.01 0.00, P < 0.01), (Fig. 1 ).
Globulin/antibody binding studies (Fig. 2) Antibodies bound to the perfused kidney in a dose related fashion. AntiGBM-Ab was shown to localize to the GBM on IF, with no significant staining of the vascular endothelium or renal tubular basement membrane. There was no glomerular deposition of rat C3 on IF. despite normal protein excretion rates at the lower dose. These data demonstrate that hemodynamie changes are not contributing significantly to antibody induced proteinuria and suggest that there are different KFA thresholds for the permelectivity and hemodynamic changes induced by antiGBM antibody [381.
The addition of antiGBM-Ab was associated with a significant decrease in permeability to all neutral dextran molecules over 21 A Stokes-Einstein radius, reflected by the fall in their fractional dextran clearance/sieving coefficient (Fig. 4) .
AntiGBM antibody produced a significant increase in permeability to all sizes of negatively-charged dextran sulphate moieties, (that is, increased fractional dextran clearance/sieving coefficient) indicating that antiGBM antibody administration resulted in a loss of the normal net negative charge barrier of the glomerular filter (Fig. 4) . The 385 tg/g KFA antiGBM antibody perfusions had extensive proximal convoluted tubule epithelial rat IgG staining when an F(ab) preparation of rat antiFXlA antibody was added to the perfusate reservoir, confirming that antiGBM antibody produced an increase in glomerular protein permeability. Antibody binding at lower KFA levels was not associated with significant changes in the rate of protein excretion and there was no antiFXlA staining of proximal convoluted tubule epithelium in these preparations.
Discussion
The isolated rat kidney perfused with an oxygenated, cell-free, oncotically-active solution is an accepted model for a variety of physiological, metabolic and pharmacological studies of renal function [39, 401 . Although only rarely used for nephroimmunological studies [22, 42] , the facility with which perfusate composition may be altered provides a unique opportunity to directly study the effects of the sequential addition of factors which may play a role in immune renal injury. In the current study control values for GFR, RYR, and protein excretion are comparable to those previously reported for the technique [39, 401.
The landmark study of Cochrane et al established the role of complement and neutrophils in producing injury following antiGBM antibody deposition [10] . Subsequently many authors have confirmed the importance of the complement/neutrophil interaction in antiGBM GN, which is regarded as a neutrophil-dependent model of renal injury [4, 5, 9] . However several observations suggest that additional, neutrophil-independent mechanisms of glomerular injury also exist [15] . Even in the initial study of Cochrane et al, it was observed that large doses of antiGI3M antibody caused an acute increase in urinary protein excretion which could not be prevented by neutrophil or complement depletion [10] . In the interpretation of these findings it was suggested that alternate mediator systems (such as kinins and fibrin) were activated by high levels of antiGBM binding, or that despite relative complement and polymorph depletion, high levels of antibody binding could induce sufficient complement fixation and polymorph influx to produce injury. The current experiments utilizing the IPK confirm that antiGBM antibody administration in appropriate doses can produce an increased glomerular protein excretion in the rat kidney without the involvement of any circulating soluble inflammatory mediators or inflammatory cells. These IPK studies clearly demonstrate the potential for acute renal injury secondary to glomerular antibody deposition. However, in vivo, glomerular antibody deposition initiates local complement activation with consequent leucocyte accumulation. In vivo each component of this 'triad' of inflammatory mediators (that is, antibody deposition, complement activation, and leucocyte infiltration) undoubtedly contributes to acute glomerular injury. The relative contribution of each of these mediators varies in relationship to species [10, [16] [17] [18] [19] [20] , the site of antigen-antibody interaction [43] and the quantity of deposited immunoglobulin.
Much information has accrued to suggest that albumin is normally prevented from crossing the glomerular filtration barrier largely by virtue of the net negative charge on the glomerular filter [22] [23] [24] [25] [26] . Prior to investigating the mechanism of increased protein excretion with antiGBM antibody binding, the normal permselectivity characteristics of control IPK preparations were determined. These studies demonstrated that glomerular permselectivity for both neutral and negatively charged dextrans of various molecular size was essentially similar to that of the SD rat in vivo [21] . Our control IPK system showed an increased protein excretion, when compared with the rat in vivo, of similar magnitude to that reported by other investigators [22, 33, [39] [40] [41] [42] . It has been suggested that this increased albumin excretion is of a non-glomerular origin [221. However, micropuncture studies in the IPK show an increased early proximal tubule (EPT) albumin concentration compared with in vivo [42] , indicating that the IPK has either an increased seiving coefficient for albumin or a failure of EPT albumin reabsorption. An increased seiving coefficient for albumin in the IPK cannot be on the basis of an abnormality of the size or charge selectivity of the glomerular filter, as fractional dextran clearances are essentially similar to in vivo values [21] . It is likely that the markedly altered hemodynamics of the IPK, together with alterations in the secondary structure of albumin in the IPK perfusate, results in an increased albumin sciving coefficient despite normal size and charge selectivity (that is, normal fractional dextran clearances) [21, 41] .
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The addition of antiGBM antibody produced a decrease in permeability to all but the smallest neutral dextran molecules (<21A), with a marked increase in permeability to all dextran sulphate moieties. These two results demonstrate that the normal negative charge barrier of the glomerular filter was destroyed by the addition of antiGBM antibody. The loss of the charge barrier in association with the development of proteinuria suggests that the two are causally linked. The changes in gloinerular permselectivity in the IPK with antiGBM antibody administration alone are similar to those reported by Chang et al in an in vivo model of the autologous phase of antiGBM glomerulonephritis involving antibody, complement, and cellular infiltration [44, 451 . However, in in vivo studies involving the simultaneous activation of multiple cellular and humoral mediators at the site of injury, the individual contributions to injury cannot be discerned. The current studies demonstrate that loss of the negative charge barrier with an increased glomerular protein permeability can be induced by antibody deposition alone.
The mechanism of the antiGBM antibody induced loss of the negative charge barrier and the increased protein excretion rate seen in the current study was uncertain. Antibody may bind to specific basement membrane antigenic determinants, which are important in the maintenance of normal permselectivity, and by altering these may directly lead to abnormal membrane permeability. Alternatively, antibody binding may stimulate the release of inflammatory mediators from intrinsic renal parenchymal cells, and these substances might then alter membrane permeability to albumin. The potential significance of the release of such inflammatory mediators by intrinsic renal cells has recently been reinforced with the demonstration by Pirotsky et al, of the generation and release of such a mediator (that is, platelet activating factor) from renal parenchymal cells [461.
Summary
These studies in an IPK system have demonstrated the ability of antiGBM antibody to produce injury in the rat kidney in the absence of all other circulating inflammatory mediators. The increased protein excretion which occurred with antibody binding to the GBM was associated with loss of the functional negative charge barrier on the GBM. Such inflammatory cell-independent immune renal injury may potentially be important in experimental glomerulonephritis and may help explain the inflammatory cell independent injury seen in many forms of human glomerulonephritis.
